{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05163028",
            "orgStudyIdInfo": {
                "id": "HBI-2376-101"
            },
            "organization": {
                "fullName": "HUYABIO International, LLC.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations",
            "officialTitle": "A Phase 1, Open-Label, Dose Escalation of HBI-2376 in Patients With Advanced Malignant Solid Tumors Harboring KRAS or EGFR Mutations",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-dose-escalation-study-of-inhibitor-in-patients-with-solid-tumors-harboring-kras-of-egfr-mutations"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-12-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-11-24",
            "studyFirstSubmitQcDate": "2021-12-06",
            "studyFirstPostDateStruct": {
                "date": "2021-12-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "HUYABIO International, LLC.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated dose and recommended Phase II dose of HBI-2376 and characterize its pharmacokinetic profile.",
            "detailedDescription": "A Phase 1, Open-Label, Dose Escalation of HBI-2376 in Patients with Advanced Malignant Solid Tumors Harboring KRAS or EGFR Mutations. The primary and secondary objectives are:\n\n1. To determine the MTD and recommended Phase 2 dose (RP2D), of HBI-2376 as an oral monotherapy for advanced solid tumors harboring KRAS or EGFR mutations\n2. To characterize the PK of HBI-2376 in subjects with advanced malignant solid tumors harboring KRAS or EGFR mutations\n\nHBI-2376 is a SHP2 Inhibitor and will be dosed once daily throughout the escalation and expansion phase. Up to 42 subjects will be enrolled sequentially into the 3+3 dose escalation and monitored throughout the study for safety and tolerability. The dose escalation phase will consist of 6 cohorts, with doses ranging from 6 to 40mg. Once the MTD of RP2D is established, additional 6 subjects will be enrolled into the expansion phase at that dose level."
        },
        "conditionsModule": {
            "conditions": [
                "Non Small Cell Lung Cancer",
                "Colorectal Cancer",
                "Pancreatic Cancer",
                "Solid Tumor",
                "Cancer",
                "Cancer of Pancreas",
                "Cancer of Colon"
            ],
            "keywords": [
                "KRAS",
                "EGFR",
                "SHP2",
                "FIH"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "3+3 Dose Escalation Design with Expansion",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 42,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation and Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "HBI-2376 will be given orally in ascending doses (escalation cohort), until the maximum tolerated dose or recommended Phase 2 dose is reached. Up to 6 patients will then be enrolled in the expansion cohort at the recommended dose.",
                    "interventionNames": [
                        "Drug: HBI-2376"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "HBI-2376",
                    "description": "SHP2 Inhibitor",
                    "armGroupLabels": [
                        "Dose Escalation and Expansion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D), of HBI-2376 as an oral monotherapy for advanced solid tumors harboring KRAS or EGFR mutations.",
                    "description": "Safety endpoints: Incidence of dose-limiting toxicities (DLTs), adverse events (AEs), and serious adverse events (SAEs) overall, by severity, by relationship to HBI-2376, and those that led to discontinuation of HBI-2376",
                    "timeFrame": "Up to 36 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Pharmacokinetic variables including maximum plasma concentration (Cmax)",
                    "description": "Pharmacokinetic variables including maximum plasma concentration (Cmax)",
                    "timeFrame": "Cycle 1 (28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including minimum plasma concentration (Cmin)",
                    "description": "Pharmacokinetic variables including minimum plasma concentration (Cmin)",
                    "timeFrame": "Cycle 1 (28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including Area Under the Curve (AUC)",
                    "description": "Pharmacokinetic variables including Area Under the Curve (AUC)",
                    "timeFrame": "Cycle 1 (28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including clearance",
                    "description": "Pharmacokinetic variables including clearance",
                    "timeFrame": "Cycle 1 (28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including serum half-life",
                    "description": "Pharmacokinetic variables including serum half-life",
                    "timeFrame": "Cycle 1 (28 days)"
                },
                {
                    "measure": "Pharmacokinetic variables including volume of distribution",
                    "description": "Pharmacokinetic variables including volume of distribution",
                    "timeFrame": "Cycle 1 (28 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Male or female at least 18 years of age at the time of signing the ICF prior to initiation of any study specific activities/procedures\n* Advanced malignant solid tumors with KRAS or EGFR mutations diagnosed by histology or cytology\n* Relapsed or refractory to, or intolerant of, or refuse approved or standard of care established therapy known to provide clinical benefit for disease\n* At least 1 measurable target lesion that meets the definition of RECIST v1.1\n* ECOG Performance Status of 0 or 1\n* Demonstrate adequate organ function\n* Must be able to swallow oral medications and must not have gastrointestinal abnormalities that significantly affect drug absorption\n\nKey Exclusion Criteria:\n\n* History of another concurrent malignancy within 3 years prior to study entry, unless the malignancy was treated with curative intent and the likelihood of relapse is \\<5% in 2 years Note: Subjects with a history of squamous or basal cell carcinoma of the skin or carcinoma in the situ of the cervix may be enrolled\n* Untreated or symptomatic central nervous system (CNS) metastases Note: Subjects with asymptomatic treated CNS metastases are eligible provided they have been clinically stable and not requiring steroids for at least 4 weeks\n* Clinically significant cardiovascular disease, including stroke or myocardial infarction within 6 months\n* Any unresolved Grade 2 or greater toxicity from previous anti-cancer therapy, except alopecia, within 4 weeks of first study treatment administration\n* Active autoimmune diseases or history of autoimmune diseases that may relapse\n* Pregnant or nursing\n* Prior treatment with any SHP2 inhibitors\n* Any condition that required systemic treatment with either corticosteroids (\\>10 mg daily of prednisone or equivalent) or other immunosuppressive medication \u226414 days before the first study treatment administration\n* Treatment with other investigational drugs/devices within 4 weeks prior to first study treatment administration",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John Ning, MD,PhD,FAIC",
                    "role": "CONTACT",
                    "phone": "858-280-1866",
                    "email": "jning@huyabio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ravi Salgia, MD",
                    "affiliation": "City of Hope Comprehensive Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Susan Hmwe",
                            "role": "CONTACT",
                            "phone": "626-218-4404",
                            "email": "shmwe@coh.org"
                        },
                        {
                            "name": "Ravi Salgia, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "California Cancer Associates for Research and Excellence, Inc. (cCare)",
                    "status": "RECRUITING",
                    "city": "Encinitas",
                    "state": "California",
                    "zip": "92024",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christina Spencer",
                            "role": "CONTACT",
                            "phone": "760-452-3909",
                            "email": "cspencer@ccare.com"
                        },
                        {
                            "name": "Alberto Bessudo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.03699,
                        "lon": -117.29198
                    }
                },
                {
                    "facility": "Providence Medical Foundation",
                    "status": "RECRUITING",
                    "city": "Fullerton",
                    "state": "California",
                    "zip": "92835",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Noli Raz",
                            "role": "CONTACT",
                            "phone": "717-446-5642",
                            "email": "Noli.Raz@stjoe.org"
                        },
                        {
                            "name": "David J Park, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.87029,
                        "lon": -117.92534
                    }
                },
                {
                    "facility": "California Cancer Associates for Research and Excellence, Inc. (cCare)",
                    "status": "RECRUITING",
                    "city": "San Marcos",
                    "state": "California",
                    "zip": "92069",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Christina Spencer",
                            "role": "CONTACT",
                            "phone": "760-452-3909",
                            "email": "cspencer@ccare.com"
                        },
                        {
                            "name": "Alberto Bessudo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.14337,
                        "lon": -117.16614
                    }
                },
                {
                    "facility": "Sarcoma Oncology",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90403",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Victoria S Chua-Alcala, MD, CLS",
                            "role": "CONTACT",
                            "phone": "310-552-9999",
                            "email": "vchua@sarcomaoncology.com"
                        },
                        {
                            "name": "Sant Chawla, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "UCLA Hematology/Oncology",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90404",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joanna Gutierrez",
                            "role": "CONTACT",
                            "phone": "310-633-8400",
                            "phoneExt": "16370",
                            "email": "mailto:JGGutierrez@mednet.ucla.edu"
                        },
                        {
                            "name": "Jonathan Goldman, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "Orlando Health, Inc.",
                    "status": "RECRUITING",
                    "city": "Orlando",
                    "state": "Florida",
                    "zip": "32806",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kiera Grofsik",
                            "role": "CONTACT",
                            "phone": "321-841-6626",
                            "email": "kiera.grofsik@orlandohealth.com"
                        },
                        {
                            "name": "Sajeve Thomas, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.53834,
                        "lon": -81.37924
                    }
                },
                {
                    "facility": "BRCR Medical Center",
                    "status": "RECRUITING",
                    "city": "Plantation",
                    "state": "Florida",
                    "zip": "33322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ines Padron",
                            "role": "CONTACT",
                            "phone": "561-447-0614",
                            "phoneExt": "102",
                            "email": "ipadron@brcrglobal.com"
                        },
                        {
                            "name": "Harshad Amin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.13421,
                        "lon": -80.23184
                    }
                },
                {
                    "facility": "Gabrail Cancer Center",
                    "status": "RECRUITING",
                    "city": "Canton",
                    "state": "Ohio",
                    "zip": "44718",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kim Roby",
                            "role": "CONTACT",
                            "phone": "330-492-3345",
                            "phoneExt": "227",
                            "email": "kroby@gabrailcancercenter.com"
                        },
                        {
                            "name": "Nashat Gabrail, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.79895,
                        "lon": -81.37845
                    }
                },
                {
                    "facility": "Texas Oncology - Tyler",
                    "status": "RECRUITING",
                    "city": "Tyler",
                    "state": "Texas",
                    "zip": "75702",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Penny Watkins, RN",
                            "role": "CONTACT",
                            "phone": "903-579-9800",
                            "email": "penny.watkins@usoncology.com"
                        },
                        {
                            "name": "Donald A Richards, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.35126,
                        "lon": -95.30106
                    }
                },
                {
                    "facility": "Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cynthia DeLeon",
                            "role": "CONTACT",
                            "phone": "210-580-9521",
                            "email": "cdeleon@nextoncology.com"
                        },
                        {
                            "name": "Alexander Spira, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Pan American Center for Oncology Trials (PanOncology Trials)",
                    "status": "RECRUITING",
                    "city": "Rio Piedras",
                    "zip": "00935",
                    "country": "Puerto Rico",
                    "contacts": [
                        {
                            "name": "Marcia R Cruz-Correa, MD,PhD,AGAF,FASGE",
                            "role": "CONTACT",
                            "phone": "787-407-3333",
                            "email": "marcia.cruzcorrea@panoncologytrials.com"
                        },
                        {
                            "name": "Marcia R Cruz-Correa, MD,PhD,AGAF,FASGE",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 18.39745,
                        "lon": -66.04989
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010190",
                    "term": "Pancreatic Neoplasms"
                },
                {
                    "id": "D000003110",
                    "term": "Colonic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                },
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "asFound": "Cancer of Pancreas",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M6338",
                    "name": "Colonic Neoplasms",
                    "asFound": "Cancer of Colon",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}